{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T05:27:43Z","timestamp":1655098063220},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.eimc.2014.10.009","type":"journal-article","created":{"date-parts":[[2014,12,6]],"date-time":"2014-12-06T14:34:50Z","timestamp":1417876490000},"page":"39-44","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hepatotoxicidad en el lactante sano expuesto a nevirapina durante el embarazo"],"prefix":"10.1016","volume":"34","author":[{"given":"Pablo","family":"Iveli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoni","family":"Noguera-Julian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pere","family":"Soler-Palac\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Mart\u00edn-Nalda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00faria","family":"Rovira-Girabal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e0udia","family":"Fortuny-Guasch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Concepci\u00f3","family":"Figueras-Nadal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2014.10.009_bib0005","unstructured":"Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health andInterventions to Reduce Perinatal HIV Transmission in the United States [consultado May 2013]. Disponible en: http:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/PerinatalGL.pdf"},{"key":"10.1016\/j.eimc.2014.10.009_bib0010","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1086\/367898","article-title":"A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1","volume":"187","author":"Moodley","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eimc.2014.10.009_bib0015","unstructured":"McIntyre J. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection: RHL commentary. The WHO Reproductive Health Library [Internet]. 2007 [consultado 19 May 2012]. Disponible en: http:\/\/apps.who.int\/rhl\/hiv_aids\/jmicom\/es"},{"key":"10.1016\/j.eimc.2014.10.009_bib0020","series-title":"Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants: Recommendations for a Public Health Approach\u20142010 Version","year":"2010"},{"key":"10.1016\/j.eimc.2014.10.009_bib0025","series-title":"Programmatic Update: Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants: Executive Summary","year":"2012"},{"key":"10.1016\/j.eimc.2014.10.009_bib0030","series-title":"Consolidated Guidelines on Deneral HIV Care and the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach","year":"2013"},{"key":"10.1016\/j.eimc.2014.10.009_bib0035","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/jama.288.2.189","article-title":"Two-dose intrapartum\/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: A randomized trial","volume":"288","author":"Dorenbaum","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.eimc.2014.10.009_bib0040","first-page":"592","article-title":"Achievements in public health. Reduction in perinatal transmission of HIV infection\u2014United States, 1985-2005","volume":"55","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.eimc.2014.10.009_bib0045","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/00126334-200404150-00014","article-title":"Hepatotoxicity associated with nevirapine use","volume":"35","author":"Baylor","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimc.2014.10.009_bib0050","first-page":"200","article-title":"Safety of antiretroviral prophylaxis of perinatal transmission for HIV-infected pregnant women and their infants","volume":"30","author":"Mofenson","year":"2002","journal-title":"J AIDS"},{"key":"10.1016\/j.eimc.2014.10.009_bib0055","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/00126334-200407010-00002","article-title":"Maternal toxicity with continuous nevirapine in pregnancy: Results from PACTG 1022","volume":"36","author":"Hitti","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimc.2014.10.009_bib0060","unstructured":"US Food and Drug Administration FDA public health advisory for nevirapine (Viramune) [sitio web FDA]. 19 de enero de 2005 [consultado 4 May 2013]. Disponible en: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/DrugSafetyInformationforHeathcareProfessionals\/PublicHealthAdvisories\/ucm051674.htm"},{"key":"10.1016\/j.eimc.2014.10.009_bib0065","unstructured":"Grupo de expertos de la Secretar\u00eda del Plan Nacional sobre el Sida (SPNS), Grupo de Estudio de Sida (GeSIDA), Sociedad Espa\u00f1ola de Ginecolog\u00eda y Obstetricia (SEGO) y Sociedad Espa\u00f1ola de Infectolog\u00eda Pedi\u00e1trica (SEIP). Documento de consenso para el seguimiento de la infecci\u00f3n por VIH en relaci\u00f3n con la reproducci\u00f3n, embarazo, parto y profilaxis de la transmisi\u00f3n vertical del ni\u00f1o expuesto [consultado 20 Ago 2013]. Disponible en: http:\/\/www.seipweb.es\/images\/site\/pdf\/docu_oficiales\/DocEmbarazomarzo2013.pdf"},{"key":"10.1016\/j.eimc.2014.10.009_bib0070","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/00006454-200108000-00017","article-title":"Nevirapine pharmacokinetics in pregnant women and in their infants after in utero exposure","volume":"20","author":"Mirochnick","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.eimc.2014.10.009_bib0075","first-page":"280","article-title":"Safety and pharmacokinetics (pk) of nevirapine (NVP) in HIV-I infected pregnant women and their newborns. ACTG Protocol 250 Team","volume":"7","author":"Mirochnick","year":"1996","journal-title":"Pediatr AIDS HIV Infect"},{"key":"10.1016\/j.eimc.2014.10.009_bib0080","unstructured":"Felipe A, Noguera A, Fortuny C, S\u00e1nchez E, Rovira N, Sim\u00f3 M. Chronic in utero exposition to nevirapine does not cause hepatotoxicity in HIV-uninfected healthy infants [abstract 1083]. 18th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Barcelona, 19-22 de abril, 2008."},{"key":"10.1016\/j.eimc.2014.10.009_bib0085","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1086\/515641","article-title":"Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 Team","volume":"178","author":"Mirochnick","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eimc.2014.10.009_bib0090","series-title":"Review of the HIVNET 012 Perinatal HIV Prevention Study","year":"2005"},{"key":"10.1016\/j.eimc.2014.10.009_bib0095","unstructured":"U.S. National Library of Medicine, National Institutes of Health. Division of AIDS (DAIDS) Clinical Research Policies and Standard Procedures Documents [sitio web NLM]. Fecha de actualizaci\u00f3n: 20 de mayo de 2012 [consultado 10 Sep 2012]. Disponible en: http:\/\/www.niaid.nih.gov\/labsandresources\/resources\/daidsclinrsrch\/Pages\/Default.aspx"},{"key":"10.1016\/j.eimc.2014.10.009_bib0100","first-page":"1","article-title":"1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults","volume":"41","year":"1992","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.eimc.2014.10.009_bib0105","first-page":"147","article-title":"Hepatotoxicity associated with long- versus short-course HIV-prophylactic nevirapine use: A systematic review systematic review and meta-analysis from the Research on Adverse Drug events And Reports (RADAR) project","volume":"32","author":"McKoy","year":"2009","journal-title":"DrugSaf"},{"key":"10.1016\/j.eimc.2014.10.009_bib0110","first-page":"397","article-title":"Antiretroviral use in pregnancy in PACTG 316: A phase III randomized, blinded study of single-dose intrapartum\/neonatal nevirapine to reduce mother to infant HIV transmission [abstract no. 23281]","volume":"12","author":"Dorenbum-Kracer","year":"1998","journal-title":"Int Conf AIDS"},{"key":"10.1016\/j.eimc.2014.10.009_bib0115","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0140-6736(03)14341-3","article-title":"Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial","volume":"362","author":"Jackson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.eimc.2014.10.009_bib0120","unstructured":"Lallemant MG, Thaineua V, Jourdain G, Lecoeur S, Koetsawang S, Kosalaraksa P, et al. PHPT-2: nevirapine plus zidovudine for the prevention of perinatal HIV [abstract no. C10914]. 14th International Conference on AIDS; Jul 7-12; Barcelona. 2002."},{"key":"10.1016\/j.eimc.2014.10.009_bib0125","unstructured":"U.S. National Library of Medicine, National Institutes of Health. Nevirapine [sitio web NIH]. Fecha de actualizaci\u00f3n: 14 de mayo de 2013 [consultado 24 May 2013]. Disponible en: http:\/\/livertox.nlm.nih.gov\/Nevirapine.htm"},{"key":"10.1016\/j.eimc.2014.10.009_bib0130","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/00002030-200204120-00004","article-title":"Effect of HIV-1 antiretroviral prophylaxis on hepatic and hematological parameters of African infants","volume":"16","author":"Taha","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2014.10.009_bib0135","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/00126334-200312150-00006","article-title":"Safety and trough concentrations of nevirapine prophylaxis given daily, twice weekly, or weekly in breast-feeding infants from birth to 6 months","volume":"34","author":"Shetty","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimc.2014.10.009_bib0140","series-title":"13th International Conference on STD & AIDS in Africa (ICASA), 21 al 26 de septiembre","article-title":"Efficacy of postnatal prophylaxis of 3TC or NVP in breastfed children to prevent MTCT through breastfeeding, the SIMBA study","author":"Pakker","year":"2003"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X14003541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X14003541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T05:26:50Z","timestamp":1538026010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X14003541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0213005X14003541"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2014.10.009","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatotoxicidad en el lactante sano expuesto a nevirapina durante el embarazo","name":"articletitle","label":"Article Title"},{"value":"Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimc.2014.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Espa\u00f1a, S.L.U. y Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. All rights reserved.","name":"copyright","label":"Copyright"}]}}